PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33789427-0	2021	LY3023414 inhibits both osteogenesis and osteoclastogenesis through the PI3K/Akt/GSK3 signalling pathway.	LY3023414	0-9	thymoma viral proto-oncogene 1	Mus musculus	77-80	
33789427-10	2021	RESULTS: LY3023414 attenuated PI3K/protein kinase B (Akt)/GSK3-dependent activation of beta-catenin and nuclear factor-activated T cell 1 (NFATc1) during osteogenesis and osteoclastogenesis, respectively.	LY3023414	9-18	thymoma viral proto-oncogene 1	Mus musculus	53-56	
33789427-14	2021	CONCLUSION: LY3023414 can suppress osteogenesis and osteoclastogenesis through inhibition of the PI3K/Akt/GSK3 signalling pathway, which highlights the potential benefits and side effects of LY3023414 for future clinical applications.	LY3023414	12-21	thymoma viral proto-oncogene 1	Mus musculus	102-105